Bian Wentao, Liu Shuang, Zhou Ping, Yan Kangling, Zhang Jiancheng, Bian Wenkai, Zhang Qiang, Ding Lu
Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Belarusian State University, Minsk, Belarus.
J Artif Organs. 2024 Nov 5. doi: 10.1007/s10047-024-01480-w.
Critically acute and ill and Obstetrical patients constitute a unique clinical population with a high mortality rate. Extracorporeal membrane oxygenation (ECMO) is gradually being used in obstetrical acute and critically ill patients and has shown great advantages. PubMed, Embase, Web of Science, Chinese CNKI Database, and Cochrane Library databases were systematically searched from the earliest available date to March 15, 2024, to obtain relevant studies on extracorporeal membrane oxygenation in obstetric patients. After screening the literature, data were independently extracted and summarized using random effects or fixed effects models, depending on the magnitude of heterogeneity. A total of 38 studies (917 patients) were included. The overall survival rate for critically ill obstetric patients supported by ECMO was 65% (56-74%). Among these, the survival rates for antepartum and postpartum patients were 70% (55-84%) and 63% (47-78%) respectively. The survival rates of obstetric patients supported by VV-ECMO and VA-ECMO were 70% (56-83%) and 56% (44-68%), respectively. This article systematically reports the survival rate of critically ill obstetric patients under ECMO support. The survival rate for these patients is significantly higher than the overall survival rate of all patients receiving ECMO support. Survival rates were similar for prenatal and postpartum patients but survival rates for patients supported by VV-ECMO were significantly higher than those supported by VA-ECMO. Further research is needed to explore the benefits of ECMO for obstetric patients with different disease types.
急危重症产科患者是一类死亡率较高的特殊临床群体。体外膜肺氧合(ECMO)逐渐应用于产科急危重症患者,并显示出巨大优势。对PubMed、Embase、Web of Science、中国知网数据库和Cochrane图书馆数据库从最早可用日期至2024年3月15日进行系统检索,以获取关于产科患者体外膜肺氧合的相关研究。筛选文献后,根据异质性大小,使用随机效应或固定效应模型独立提取和汇总数据。共纳入38项研究(917例患者)。接受ECMO支持的危重症产科患者的总体生存率为65%(56%-74%)。其中,产前和产后患者的生存率分别为70%(55%-84%)和63%(47%-78%)。接受VV-ECMO和VA-ECMO支持的产科患者的生存率分别为70%(56%-83%)和56%(44%-68%)。本文系统报道了ECMO支持下危重症产科患者的生存率。这些患者的生存率显著高于所有接受ECMO支持患者的总体生存率。产前和产后患者的生存率相似,但接受VV-ECMO支持的患者的生存率显著高于接受VA-ECMO支持的患者。需要进一步研究以探索ECMO对不同疾病类型产科患者的益处。